Monday, November 10, 2008

FuturePundit: Crestor Cuts Mortality Risks From High hs-CRP Levels

For people with normal cholesterol but high scores in a test for the inflammation marker high-sensitivity C-reactive protein (hs-CRP) the statin drug rosuvastin (Crestor) very substantially cuts cardiovascular disease risks and ...Read More

No comments: